Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Peregrine Pharma New (PPHM)

0.566 0 (+0.071%)

5/26/2017  4:00pm

Open:

0.568

Pre. Close:

0.566

High:

0.570

Low:

0.555

Volume:

624,999

Market Cap:

168.50M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.58 - 0.6

0.6 - 0.63

Low:

0.53 - 0.54

0.54 - 0.56

Close:

0.55 - 0.57

0.57 - 0.6

Technical analysis  (as of: 2017-05-26 4:39:56 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 0.73     One year: 0.79

Support:

Support1: 0.53    Support2: 0.44

Resistance:

Resistance1: 0.62    Resistance2: 0.68

Pivot:

0.58

Moving Averages:

MA(5): 0.56     MA(20): 0.59

MA(100): 0.52     MA(250): 0.43

MACD:

MACD(12,26): -0.01     Signal(12,26,9): -0.01

%K %D:

%K(14,3): 37.81     %D(3): 33.26

RSI:

RSI(14): 42.52

52-Week:

High: 0.774  Low: 0.282  Change(%): 34.8

Average Vol(K):

3-Month: 2147  10-Days 864

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PPHM has closed above bottom band by 30.5%. Bollinger Bands are 39% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 15 Dec 2016 18:33:45 GMT
Peregrine Pharmaceuticals Reported Stellar Quarterly Results - So Why Did The ...

Tue, 14 Mar 2017 00:12:50 GMT
Peregrine Pharmaceuticals' (PPHM) CEO Steve King on Q3 2017 Results - Earnings ...

Thu, 04 May 2017 11:37:30 GMT
Implied Volatility Surging for Peregrine Pharmaceuticals (PPHM) Stock Options

Sun, 31 Jul 2016 14:20:27 GMT
Peregrine Pharmaceuticals: Top 10 Reasons To Consider A 11.9% Yield From This ...

Tue, 13 Dec 2016 01:46:50 GMT
Peregrine Pharmaceuticals' (PPHM) CEO Steve King on Q2 2017 Results - Earnings ...

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

297.00

Shares Float (M)

268.98

% Held by Insiders

4.45

% Held by Institutions

17.60

Shares Short (K)

4400

Shares Short Prior Month (K)

4250

Stock Financials

EPS

-0.160

EPS Est. Current Year

-0.120

EPS Est. Next Year

-0.050

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.150

PEG Ratio

Profit Margin

-59.43

Operating Margin

-59.60

Return on Assets (ttm)

-18.9

Return on Equity (ttm)

-69.6

Qtrly Rev. Growth

60.2

Gross Profit (p.s.)

0.073

Sales Per Share

0.197

EBITDA (p.s.)

-0.109

Qtrly Earnings Growth

Operating Cash Flow (M)

-33.23

Levered Free Cash Flow (M)

-21.84

FoxReading.com

Valuation

P/E

-3.54

P/E Growth Ratio

P/BV

3.77

P/S

2.87

P/CF

-5.06

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2016-02-12

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.